04.08.2021 • News

BASF and Eni to Develop Bio-based Propanol

BASF and Eni have agreed to jointly develop new technology to produce bio-propanol from glycerin, a byproduct from the production of industrial biodiesel, or fatty acid methyl ester (FAME).

The technology being developed involves converting the glycerin to propanol via a novel catalytic hydrotreatment process. The partners said their approach comprises applying a high-pressure hydrogenation reaction over a BASF catalyst, ensuring that the bio-propanol is produced with a high yield and purity while minimizing byproducts.

More than half of the world’s glycerin production originates as a byproduct of the biodiesel industry with every ton of biodiesel producing roughly 10% glycerin. Because biodiesel production has expanded over the years, global glycerin production has climbed from 200,000 t in 2003 to about 5 million t in 2020.

“This collaboration, which allows us to accelerate innovation and dramatically decrease time to market, is consistent with Eni’s strategy for the development of advanced-generation biofuels supply chains from feedstocks that do not compete with food supply chains,” said Luisa Lavagnini, Eni’s head of research and technological innovation.

The bio-propanol could potentially reduce greenhouse gas emissions by between 65-75% compared with fossil fuels, according to BASF and Eni. It could also be easily added as a drop-in biofuel component to gasoline. Because bio-propanol has a very high octane number as well as better physicochemical properties than bioethanol, it is a valuable component for the preparation of premium gasoline, they added.

Author: Elaine Burridge, Freelance Journalist

BASF and Eni will jointly develop new technology to produce bio-propanol from...
BASF and Eni will jointly develop new technology to produce bio-propanol from glycerin, a byproduct from the production of industrial biodiesel, or fatty acid methyl ester. The technology involves converting the glycerin to propanol via a catalytic hydrotreatment process. (c) BASF

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.